Skip to content
Screener

Trevi Therapeutics, Inc. TRVI Finance Lease Principal Payments

Finance Lease Principal Payments at other companies

TRV
Trevi Therapeutics, Inc.TRVI
$0-100%
Lithium Americas logo
Lithium AmericasLAC
$1.22M+1.7%
Photronics logo
PhotronicsPLAB
$2.75K-99.8%
The J.M. Smucker Company logo
The J.M. Smucker CompanySJM
$1M+25.0%
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
$156K-51.2%
Radiant Logistics logo
Radiant LogisticsRLGT
$73K-62.6%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.64B+196%
Enterprise value$2.62B+238%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The source filing: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026.

Filed
Mar 17, 2026, 12:00 AM EDT
Fiscal year
FY2025
Accession
0001193125-26-110783
Line itemYear Ended December 31, 2025Year Ended December 31, 2024
Proceeds from disgorgement of beneficial owner's short-swing profits725
Proceeds from employee stock purchase plan11870
Payments of offering costs(809)
Payments of finance lease(11)(126)
Proceeds from at-the-market sales, net of commissions14,146
Net cash provided by financing activities121,01361,484
Net (decrease) increase in cash and cash equivalents(15,183)1,700
Cash and cash equivalents at beginning of period34,09732,397

Item 16. Form 10-K Summary

FAQ

What is Trevi Therapeutics, Inc.'s finance lease principal payments?
Trevi Therapeutics, Inc. (TRVI) reported finance lease principal payments of $0 in Q4 2025.
How has Trevi Therapeutics, Inc.'s finance lease principal payments changed year-over-year?
Trevi Therapeutics, Inc.'s finance lease principal payments decreased by 100.0% year-over-year, from $31K to $0.
What is the long-term trend for Trevi Therapeutics, Inc.'s finance lease principal payments?
Over 2 years (2023 to 2025), Trevi Therapeutics, Inc.'s finance lease principal payments has grown at a -66.1% compound annual growth rate (CAGR), from $96K to $11K.
What does finance lease principal payments mean?
Represents the cash outflow for the reduction of the principal portion of outstanding finance lease obligations. This metric reflects the company's commitment to servicing long-term lease liabilities for assets used in operations. Monitoring this helps assess the company's fixed-obligation debt burden and cash flow management.

Ask your AI about Trevi Therapeutics, Inc.'s finance lease principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude